1. ScholarBank@NUS

Ross Andrew Soo

rp03556

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Ross Andrew Soo
(not current staff)
Variants
Ross, S.
Soo, R.
Soo, R.-A.
Soo, R.A.
Soo, Ross
 
Main Affiliation
 
Faculty
 
Email
csiras@nus.edu.sg
 

Publications

Results 41-60 of 91 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
4114-Aug-2020Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.Chong, Wan Qin; Lim, Chwee Ming ; Sinha, Arvind Kumar ; Tan, Chee Seng ; Chan, Gloria Hui Jia; Huang, Yiqing; Barr Kumarakulasinghe, Nesaretnam; Sundar, Raghav ; Jeyasekharan, Anand D ; Loh, Woei Shyang ; Tay, Joshua K. ; Yadav, Kritika ; Wang, Lingzhi ; Wong, Andrea L. ; Kong, Li Ren ; Soo, Ross Andrew ; Lau, Jieying Amelia ; Soon, Yu Yang ; Goh, Robby Miguel; Ho, Francis Cho Hao ; Chong, Siew Meng ; Lee, Soo-Chin ; Loh, Kwok Seng ; Tai, Bee Choo ; Lim, Yaw Chyn ; Goh, Boon Cher 
422013Isolation and retrieval of circulating tumor cells using centrifugal forcesHou, H.W.; Warkiani, M.E.; Khoo, B.L.; Li, Z.R.; Soo, R.A. ; Tan, D.S.-W.; Lim, W.-T.; Han, J.; Bhagat, A.A.S.; Lim, C.T. 
43Apr-2006Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drugTham, L.-S.; Lee, H.-S.; Wang, L. ; Yong, W.-P. ; Fan, L.; Ong, A.-B.; Sukri, N.; Soo, R. ; Lee, S.-C. ; Goh, B.-C.
442011Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancerTan, W.L.; Bhattacharya, B. ; Loh, M. ; Balasubramanian, I. ; Akram, M.; Dong, D. ; Wong, L. ; Thakkar, B. ; Salto-Tellez, M. ; Soo, R.A. ; Fichtner, I.; Iacopetta, B.; Soong, R. 
522-May-2021Lung Cancer in SingaporeAng, Yvonne LE; Chia, Puey Ling; Chua, Kevin LM; Devanand, Anantham ; Leong, Cheng Nang ; Liew, Charlene JY ; Ong, Boon Hean ; Samol, Jens; Seet, Ju Ee ; Tam, John KC ; Tan, Daniel SW ; Teo, Lynette LS ; Soo, Ross A 
6Sep-2008Lung cancer response to gefitinib, then erlotinib, then gefitinib againWong, A.S.; Seto, K.-Y.; Chin, T.-M. ; Soo, R.A. 
71-Jul-2015MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell CarcinomaKong, Li Ren ; Chua, Kian Ngiap ; Sim, Wen Jing ; Ng, Hsien Chun ; Bi, Chonglei; Ho, Jingshan ; Nga, Min En ; Pang, Yin Huei ; Ong, Weijie Richard; Soo, Ross Andrew ; Huynh, The Hung ; Chng, Wee Joo ; Thiery, Jean-Paul ; Goh, Boon Cher 
82011Modelling and estimating dynamics of tumor shrinkage with Blenx and KinferXLecca, P.; Kahramanoǧullari, O.; Morpurgo, D.; Priami, C.; Soo, R.A. 
9Jun-2010Non-small cell lung cancer presenting with neoplastic fever at diagnosis and relapseZee, Y.K.; Soo, R.A. 
102014Novel SNP improves differential survivability and mortality in non-small cell lung cancer patientsMah, T.L; Yap, X.N.A; Limviphuvadh, V; Li, N; Sridharan, S; Kuralmani, V; Feng, M ; Liem, N; Adhikari, S; Yong, W.P ; Soo, R.A ; Maurer-Stroh, S ; Eisenhaber, F ; Tong, J.C 
111-Nov-2018NSCLC PATIENTS WITH BOTH WILDTYPE EGFR AND HIGH CD151 EXPRESSION HAVE POORER DISEASE OUTCOMEWong, Amanda; Nga, Min En ; Wong, Hung Chew; Soo, Ross ; An, Omer ; Yang, Henry ; Tam, John KC ; Seet, Ju Ee ; Lim, Yaw Chyn ; Thai, Tran 
122006Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinomaWong, A.S.C.; Soo, R.A. ; Lim, H.L.; Goh, B.C. ; Lu, J.J. ; Shakespeare, T.P.; Loh, K.S. ; Tan, K.S.; Hsieh, W.S.; Chua, E.T.
1315-Feb-2009Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancerHsieh, W.-S. ; Soo, R. ; Pen, B.-K.; Loh, T.; Dong, D.; Son, D.; Wong, L.-S.; Green, S.; Chiao, J.; Cui, C.-Y.; Lai, Y.-F.; Lee, S.-C. ; Mow, B.; Soong, R.; Salto-Tellez, M.; Goh, B.-C.
142016Pharmacogenetics-Guided Phase i Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursSoo, R.A ; Syn, N; Lee, S.-C; Wang, L; Lim, X.-Y; Loh, M; Tan, S.-H ; Zee, Y.-K; Wong, A.L.-A ; Chuah, B; Chan, D; Lim, S.-E; Goh, B.-C ; Soong, R ; Yong, W.-P 
151-Jun-2022Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patientsHuang, Yiqing; Aminkeng, Folefac ; Wong, Alvin SC; Tay, Sen Hee ; Zhao, Joseph J; Ang, Yvonne; Soo, Ross A ; Goh, Boon Cher 
16Aug-2011Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancerTan, E.-H.; Goss, G.D.; Salgia, R.; Besse, B.; Gandara, D.R.; Hanna, N.H.; Yang, J.C.-H.; Thertulien, R.; Wertheim, M.; Mazieres, J.; Hensing, T.; Lee, C.; Gupta, N.; Pradhan, R.; Qian, J.; Qin, Q.; Scappaticci, F.A.; Ricker, J.L.; Carlson, D.M.; Soo, R.A. 
17Nov-2011Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignanciesYong, W.P. ; Goh, B.C.; Soo, R.A. ; Toh, H.C.; Ethirajulu, K.; Wood, J.; Novotny-Diermayr, V.; Lee, S.C. ; Yeo, W.L. ; Chan, D.; Lim, D.; Seah, E.; Lim, R.; Zhu, J.
181-Aug-2003Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group studySoo, R.A. ; Lim, H.L.; Wang, L.Z. ; Lee, H.S.; Millward, M.J.; Tok, L.T.; Lee, S.C. ; Lehnert, M.; Goh, B.C.
1923-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
201-Jun-2022Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast CancerLim, JSJ ; Wong, ALA ; Ow, SGW ; Ngoi, NYL ; Chan, GHJ; Ang, YLE; Chong, WQ; Lim, SE ; Lim, YW; Lee, M; Choo, JRE; Tan, HL; Yong, WP ; Soo, RA ; Tan, DSP ; Chee, CE ; Sundar, R ; Yadav, K ; Jain, S ; Wang, L ; Tai, BC ; Goh, BC ; Lee, SC